| Date | Price Target | Rating | Analyst |
|---|
New York, New York, Feb. 20, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR)) ("DT Cloud" or the "SPAC"), a publicly-traded special purpose acquisition company, today announced that it has cancelled the extraordinary general meeting of its shareholders that was previously scheduled for 10:00 a.m. Eastern Time on February 21, 2025 (the "EGM"), and has withdrawn from consideration by the shareholders the proposals set forth in the Company's definitive proxy statement for the EGM filed with the U.S. Securities and Exchange Commission (the "SEC") on January 27, 2025 and amended and supplemented on February 4, 14 and 19, 2025. About DT Cloud Acquisition Co
New York, New York, Feb. 19, 2025 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR)) ("DT Cloud" or the "SPAC"), a publicly-traded special purpose acquisition company, today announced that its Extraordinary General Meeting ("EGM"), previously scheduled at 10:00 a.m. Eastern Time on February 18, 2025, has been postponed to 10:00 a.m. Eastern Time on February 21, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on February 19, 2025. The Company filed a proxy supplement on February 14, 2025, as further amended on February 19, 2025, to increase the amended monthly extension fee, as proposed in the Proposal 1 to the EGM, to $0.
New York, New York, Oct. 23, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR))) ("DT Cloud" or the "SPAC"), a publicly-traded special purpose acquisition company, and Maius Pharmaceutical Co., Ltd. ("Maius" or the "Company"), a biopharmaceutical R&D company, announced that they had entered into a definitive business combination agreement (the "Business Combination Agreement") for the merger transactions (the "Business Combination," and the transactions in connection with the Business Combination collectively, the "Transaction"). As contemplated in the Business Combination Agreement, upon closing of the Transaction, Maius will become a wholly-owned subsi
New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR))) (the "Company") today announced that it has entered into a non-binding letter of intent ("LOI") for a business combination with Shanghai Maius Pharmaceutical Technology Co., LTD ("Shanghai Maius"). Founded in 2015, Shanghai Maius is a biopharmaceutical R&D company focusing on innovative formulations and targeted small-molecule chemical drugs. Its core products include small-molecule chemical drugs and peptide drugs. Under the terms of the LOI, the Company would acquire 100% of Shanghai Maius's outstanding equity and equity equivalents or all of its business, with the d
DEF 14A - DT Cloud Acquisition Corp (0001944212) (Filer)
PRER14A - DT Cloud Acquisition Corp (0001944212) (Filer)
SCHEDULE 13G - DT Cloud Acquisition Corp (0001944212) (Subject)
PRE 14A - DT Cloud Acquisition Corp (0001944212) (Filer)
8-K - DT Cloud Acquisition Corp (0001944212) (Filer)
8-K - DT Cloud Acquisition Corp (0001944212) (Filer)
DEFA14A - DT Cloud Acquisition Corp (0001944212) (Filer)
DEFA14A - DT Cloud Acquisition Corp (0001944212) (Filer)
8-K - DT Cloud Acquisition Corp (0001944212) (Filer)
DEFA14A - DT Cloud Acquisition Corp (0001944212) (Filer)
SC 13G - DT Cloud Acquisition Corp (0001944212) (Subject)
SC 13G - DT Cloud Acquisition Corp (0001944212) (Subject)
SC 13G - DT Cloud Acquisition Corp (0001944212) (Subject)
SC 13G - DT Cloud Acquisition Corp (0001944212) (Subject)
SC 13G/A - DT Cloud Acquisition Corp (0001944212) (Subject)
SC 13G - DT Cloud Acquisition Corp (0001944212) (Subject)